These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 20381630
21. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Hanania NA, Donohue JF. Proc Am Thorac Soc; 2007 Oct 01; 4(7):526-34. PubMed ID: 17878465 [Abstract] [Full Text] [Related]
22. Pharmacology and therapeutics of bronchodilators. Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacol Rev; 2012 Jul 01; 64(3):450-504. PubMed ID: 22611179 [Abstract] [Full Text] [Related]
23. Current and novel bronchodilators in respiratory disease. Spina D. Curr Opin Pulm Med; 2014 Jan 01; 20(1):73-86. PubMed ID: 24247039 [Abstract] [Full Text] [Related]
29. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends. Montuschi P, Ciabattoni G. J Med Chem; 2015 May 28; 58(10):4131-64. PubMed ID: 25587755 [Abstract] [Full Text] [Related]
30. An update on LAMA/LABA combinations for COPD. Drug Ther Bull; 2017 Jan 28; 55(1):2-5. PubMed ID: 28057707 [Abstract] [Full Text] [Related]
31. Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand. Parkin L, Barson D, Zeng J, Horsburgh S, Sharples K, Dummer J. Respirology; 2018 Jun 28; 23(6):583-592. PubMed ID: 29265705 [Abstract] [Full Text] [Related]
32. New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β2 agonists in combination or combined into a single molecule. Norman P. Expert Opin Investig Drugs; 2013 Dec 28; 22(12):1569-80. PubMed ID: 23962341 [Abstract] [Full Text] [Related]
33. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Wu J, Ye Y, Li C, Zhou W, Chang R. J Cardiovasc Pharmacol; 2019 Sep 28; 74(3):255-265. PubMed ID: 31306366 [Abstract] [Full Text] [Related]
34. Future of chronic obstructive pulmonary disease management. D'Urzo A, Vogelmeier C. Expert Rev Respir Med; 2012 Jun 28; 6(3):285-99. PubMed ID: 22788943 [Abstract] [Full Text] [Related]
35. [The stepwise approach of COPD therapy]. Watz H, Kirsten A, Greulich T. Dtsch Med Wochenschr; 2019 Jan 28; 144(1):15-20. PubMed ID: 30602182 [Abstract] [Full Text] [Related]
36. Long-acting muscarinic receptor antagonists for the treatment of respiratory disease. Cazzola M, Page C, Matera MG. Pulm Pharmacol Ther; 2013 Jun 28; 26(3):307-17. PubMed ID: 23274274 [Abstract] [Full Text] [Related]
37. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Chen AM, Bollmeier SG, Finnegan PM. Ann Pharmacother; 2008 Dec 28; 42(12):1832-42. PubMed ID: 18957624 [Abstract] [Full Text] [Related]
38. Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? Blasi F, Canonica GW, Miravitlles M. Respir Res; 2017 Jan 18; 18(1):19. PubMed ID: 28100244 [Abstract] [Full Text] [Related]
39. Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update. Matera MG, Rogliani P, Calzetta L, Cazzola M. Drug Saf; 2016 Jun 18; 39(6):501-8. PubMed ID: 26924197 [Abstract] [Full Text] [Related]
40. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators. Kitaguchi Y, Fujimoto K, Komatsu Y, Hanaoka M, Honda T, Kubo K. Respir Med; 2013 Mar 18; 107(3):394-400. PubMed ID: 23245993 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]